ALKM – Alkame Holdings Restructures Even More Debt Further Reducing Number Of Shares That Could Be Issued To Service Debt
Alkame Holdings, Inc. (OTC PINK: ALKM) has announced a significant debt restructuring agreement with Blue Citi LLC. This restructuring involves four convertible notes totaling $988,000 in principal and approximately $350,000 in accrued interest. The deal includes the nullification of all accrued interest and eliminates future interest accruals, thereby reducing the company's debt burden by about $1.0 million. This strategic move is expected to strengthen Alkame's balance sheet and facilitate new credit facilities for anticipated growth.
- Debt restructuring reduces liabilities by approximately $1.0 million.
- Elimination of accrued and future interest improves financial stability.
- Restructuring supports potential new credit facilities for growth.
- None.
LAS VEGAS, NV, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Alkame Holdings, Inc. (OTC PINK: ALKM), is pleased to announce that management continues the strengthening of its balance sheet with the execution of a debt restructuring agreement with Blue Citi LLC.
The Company's strategic debt restructuring with Blue Citi LLC, has resulted in an agreement to restructure four convertible notes held by Blue Citi. The notes, totaling
"This major debt restructuring coupled with last week's conversion of
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly owned subsidiaries manufacture products with enhanced water utilizing a proprietary technology to create products with several unique properties. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications by placement into several emerging business sectors, such as consumer bottled water and RTD products, household pet products, horticulture and agriculture applications, hand sanitizers, and many other various water-based treatment solutions to both new and existing business platforms.
For more information, visit www.alkameholdingsinc.com.
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com
Phone: 702-273-9714
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
SOURCE: Alkame Holdings, Inc.
FAQ
What is the significance of Alkame's debt restructuring on September 7, 2021?
How much debt was restructured by Alkame Holdings, Inc.?
What are the future implications of Alkame's debt restructuring for investors?
How does the debt restructuring affect Alkame's capital structure?